Timothy Marlowe

Professor Timothy Marlowe is a distinguished faculty member collaborating on research in cancer biology and drug discovery at the University of Arizona. With multiple faculty positions at the College of Medicine - Phoenix, Cancer Center, and College of Pharmacy, Dr. Marlowe is at the forefront of pioneering research in targeted therapies. As an Assistant Professor of Internal Medicine, he leads a cutting-edge drug discovery laboratory dedicated to developing novel peptides and molecules that target Focal Adhesion Kinase (FAK) for cancer treatment. Dr. Marlowe's research is primarily focused on FAK as a promising cancer drug target, delving into its critical role in tumor growth, survival, and metastasis. His innovative approach has led to the development of groundbreaking drug candidates that effectively inactivate FAK's focal adhesion targeting domain. These candidates have shown promising efficacy in pre-clinical models, particularly in the context of melanoma, paving the way for potential new therapies in cancer treatment. In addition to his research endeavors, Dr. Marlowe serves as the Director of the Molecular Discovery Core facility. In this capacity, he plays a pivotal role in facilitating drug and chemical probe discovery, providing essential resources and expertise to advance the field of targeted cancer therapies. His leadership in this area underscores his commitment to translating scientific discoveries into tangible clinical applications. Dr. Marlowe's contributions to the field of cancer biology and drug discovery have been recognized through numerous publications and presentations at national and international conferences. His work not only enhances our understanding of FAK's role in cancer but also opens new avenues for the development of targeted therapies that could significantly improve patient outcomes. Through his dedication to research and education, Dr. Timothy Marlowe continues to inspire the next generation of scientists and healthcare professionals. His collaborative efforts and innovative research are instrumental in advancing the fight against cancer, making significant strides toward more effective and personalized treatment options.